Subtopic Deep Dive
Gestational Trophoblastic Neoplasia Epidemiology
Research Guide
What is Gestational Trophoblastic Neoplasia Epidemiology?
Gestational Trophoblastic Neoplasia Epidemiology studies the incidence, geographic variations, risk factors like age, prior mole, and ethnicity, and global registries of gestational trophoblastic neoplasia.
Gestational trophoblastic neoplasia (GTN) represents the malignant end of gestational trophoblastic disease spectrum. Epidemiologic changes in GTN incidence occur across countries, with higher rates noted in Asia (Ngan et al., 2018, 426 citations; Ngan et al., 2015, 359 citations). Global registries track these patterns for surveillance (Seckl et al., 2013, 371 citations). Over 2,000 papers address related GTD epidemiology.
Why It Matters
Epidemiologic data on GTN incidence and risk factors direct public health surveillance in high-incidence regions like Asia, optimizing resource allocation (Ngan et al., 2018). Understanding age and prior mole risks informs prevention in high-risk ethnic groups (Seckl et al., 2013). These insights reduce maternal mortality through targeted registries and early detection strategies (Ngan et al., 2015).
Key Research Challenges
Geographic Variation Analysis
Mapping GTN incidence differences across regions remains challenging due to inconsistent reporting standards. Asian countries show 2-10 times higher rates than Europe (Ngan et al., 2018). Standardized global registries are needed (Seckl et al., 2013).
Risk Factor Identification
Quantifying risks from age, prior moles, and ethnicity requires large cohort studies amid confounding variables. Advanced maternal age doubles GTN risk (Ngan et al., 2015). Molecular markers aid but lack epidemiologic integration.
Registry Data Standardization
Heterogeneous data from global registries hinders trend analysis and prevention strategies. Variations in diagnostic criteria affect incidence estimates (Seckl et al., 2013). Harmonized protocols are essential (Ngan et al., 2018).
Essential Papers
Update on the diagnosis and management of gestational trophoblastic disease
Hys Ngan, Michael J. Seckl, Ross S. Berkowitz et al. · 2018 · International Journal of Gynecology & Obstetrics · 426 citations
Abstract Gestational trophoblastic disease ( GTD ) arises from abnormal placenta and is composed of a spectrum of premalignant to malignant disorders. Changes in epidemiology of GTD have been noted...
Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Michael J. Seckl, Neil J. Sebire, Rosemary A. Fisher et al. · 2013 · Annals of Oncology · 371 citations
Diagnosis and management of ectopic pregnancy
Vanitha N. Sivalingam, W. Colin Duncan, E. Kirk et al. · 2011 · Journal of Family Planning and Reproductive Health Care · 321 citations
An ectopic pregnancy occurs when a fertilised ovum implants outside the normal uterine cavity.1,–,3 It is a common cause of morbidity and occasionally of mortality in women of reproductive age. The...
New discoveries on the biology and detection of human chorionic gonadotropin
Laurence A. Cole · 2009 · Reproductive Biology and Endocrinology · 285 citations
Incidence, diagnosis and management of tubal and nontubal ectopic pregnancies: a review
Danielle M. Panelli, Catherine H. Phillips, Paula C. Brady · 2015 · Fertility Research and Practice · 265 citations
Cesarean scar pregnancy and early placenta accreta share common histology
Ilan E. Timor‐Tritsch, Ana Monteagudo, Giuseppe Calì et al. · 2013 · Ultrasound in Obstetrics and Gynecology · 245 citations
ABSTRACT Objective To determine, by evaluation of histological slides, images and descriptions of early (second‐trimester) placenta accreta ( EPA ) and placental implantation in cases of Cesarean s...
Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers
Helena C. Bartels, James D. Postle, Paul Downey et al. · 2018 · Disease Markers · 237 citations
Background . Placenta accreta spectrum (PAS) is a condition of abnormal placental invasion encompassing placenta accreta, increta, and percreta and is a major cause of severe maternal morbidity and...
Reading Guide
Foundational Papers
Start with Seckl et al. (2013, 371 citations) for core guidelines and epidemiology overview, then Ngan et al. (2015, 359 citations) for incidence changes.
Recent Advances
Study Ngan et al. (2018, 426 citations) for updated global trends and management implications.
Core Methods
Epidemiologic methods include registry surveillance, cohort incidence calculation, and risk factor modeling via hCG monitoring (Ngan et al., 2018; Seckl et al., 2013).
How PapersFlow Helps You Research Gestational Trophoblastic Neoplasia Epidemiology
Discover & Search
Research Agent uses searchPapers for 'gestational trophoblastic neoplasia incidence Asia' yielding Ngan et al. (2018), then citationGraph reveals 426 citing papers on geographic trends, and findSimilarPapers uncovers related epidemiology studies. exaSearch scans 250M+ OpenAlex papers for unpublished registry data.
Analyze & Verify
Analysis Agent applies readPaperContent to extract incidence rates from Ngan et al. (2018), verifyResponse with CoVe checks claims against Seckl et al. (2013), and runPythonAnalysis computes age-risk correlations via pandas on extracted cohort data. GRADE grading scores evidence quality for high-bias registry studies.
Synthesize & Write
Synthesis Agent detects gaps in ethnicity-risk data across papers, flags contradictions in incidence reports, then Writing Agent uses latexEditText for review drafts, latexSyncCitations integrates Ngan et al. (2018), and latexCompile generates polished epidemiology reports. exportMermaid visualizes incidence trend diagrams.
Use Cases
"Analyze GTN incidence trends by age from 2010-2020 papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas trend plot) → matplotlib incidence graph output.
"Write LaTeX review on GTN geographic variations"
Synthesis Agent → gap detection → Writing Agent → latexEditText → latexSyncCitations (Ngan 2018) → latexCompile → PDF output.
"Find code for GTN risk factor modeling"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python risk model scripts output.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ GTN epidemiology papers: searchPapers → citationGraph → GRADE grading → structured incidence report. DeepScan applies 7-step analysis with CoVe checkpoints to verify Ngan et al. (2018) claims against registries. Theorizer generates etiologic hypotheses from risk factor literature.
Frequently Asked Questions
What is Gestational Trophoblastic Neoplasia Epidemiology?
It examines GTN incidence patterns, geographic variations, and risks like age and prior mole (Ngan et al., 2018).
What methods track GTN epidemiology?
Global registries and cohort studies monitor incidence; molecular diagnostics enhance accuracy (Seckl et al., 2013).
What are key papers?
Ngan et al. (2018, 426 citations) updates epidemiology; Seckl et al. (2013, 371 citations) provides guidelines (Ngan et al., 2015, 359 citations).
What open problems exist?
Standardizing registry data and integrating ethnicity risks into models persist (Ngan et al., 2018).
Research Gestational Trophoblastic Disease Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Gestational Trophoblastic Neoplasia Epidemiology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers